We’re concerned how people living in precarious environments will be affected by the pandemic. People living in overcrowded conditions, on the streets, in makeshift camps or substandard housing are at particular risk of COVID-19. Many are already in poor health and excluded from the formal healthcare system. We know social or physical distancing will be infinitely more difficult or impossible for these groups of people. We have to find other ways to help people keep themselves protected such as mass distributions of soap, water, and, in carefully considered circumstances, reusable cloth masks.
Coronavirus COVID-19 pandemic
Our COVID-19 response focuses on three main priorities:
• supporting authorities to provide care for COVID-19 patients;
• protecting people who are vulnerable and at risk, including via vaccination;
• and keeping essential medical services running.
Across our projects, MSF teams have implemented infection prevention and control measures to protect patients and staff. Having access to protective equipment, to COVID-19 tests, to oxygen and to drugs for supportive care or treatment, is essential as COVID-19 spreads in countries with little access to these tools.
Teams are also vaccinating people to protect against COVID-19 in multiple countries. We’re also speaking out on the need for equitable access to COVID-19 tools, including vaccines and treatments.
Scroll down to read the latest news and articles from our COVID projects.
During the pandemic, babies will still be born, people will still need treatment for diseases like HIV and TB. Maintaining access to healthcare for non-COVID-19 needs is essential, including in MSF regular projects. In our projects all over the world, our teams are ensuring infection prevention and control measures are in place, setting up screening at triage zones, creating isolation areas, and providing health education to local staff and people
Protecting healthcare workers from contracting the virus is paramount for ensuring the continuity of care for general and COVID-related health needs. However, the global shortages of personal protective equipment (PPE) pose a great threat. Healthcare workers must have access to the equipment they need to do their jobs safely and effectively; countries should show solidarity and share protective equipment wherever possible.
We also must protect those most at risk of severe forms of the illness. With COVID-19, that largely means the elderly, so much of our COVID-19 response focuses on strengthening the infection control measures and protection of the elderly in nursing homes. It also concerns those who have another illness, such as diabetes, HIV or tuberculosis. We don’t yet know what the impact will be for children who suffer from severe malnutrition or for communities that have been hit hard by measles epidemics, such as in DRC or Chad.
There should be no profiteering on emerging drugs, tests, vaccines and other tools used for this pandemic. Governments must take any necessary measures – including overriding patents and other monopolies, and introducing price controls – to ensure production, supply, and availability of essential tools at an affordable price for all. High prices and monopolies of tools will only result in rationing, which will then prolong the pandemic. In addition, prices of other essential supplies such as masks, and other PPE must be kept accessible. Once approved or available, tools must be prioritised for healthcare and frontline workers first and then supplied based on equity and need.
How do we supply oxygen to COVID-19 patients?
We cannot treat a person seriously ill with COVID-19 without oxygen. 80 per cent of people hospitalised because of COVID-19 need between three and 15 litres of oxygen per minute. For the 20 per cent who remain, the needs are more severe: more than 20 litres per minute.
Oxygen is therefore vital for them: without it they risk dying. But how do we give oxygen to our patients? What are the constraints of these various methods? And how do we put these systems in place in the countries where we work, particularly in a conflict context like Yemen?
MSF is currently responding to a worldwide coronavirus pandemic, COVID-19. We have previously responded to other outbreaks of serious coronavirus, including Severe Acute Respiratory Syndrome (SARS).
While four types of coronavirus are known to cause colds, SARS and Middle East Respiratory Syndrome (MERS) can cause severe lung infections, and can be fatal. A new coronavirus known as SARS-CoV-2, because of its similarities to the virus that causes SARS, causes the new disease COVID-19.
This new coronavirus seems to target cells in the lungs, and possibly other cells in the respiratory system too. Cells infected by the virus will produce more virus particles, which can then spread to other people, for instance by coughing. COVID-19 will be a mild respiratory illness for the vast majority of people but it has a higher rate of quite severe complications for vulnerable people (elderly and people with comorbidities), than other viruses such as flu.
Five things to know about the coronavirus pandemic
We’ve never seen a global outbreak like the new coronavirus disease, or COVID-19. It threatens to overwhelm health systems and health workers everywhere unless we all take immediate action. Here are five things to know about what makes this pandemic so dangerous, and what can be done to slow the spread of the virus. Simple measures can help flatten the curve of the epidemic, including physical distancing and proper hand washing.